ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL
Institute of Hematology & Blood Diseases Hospital, China
Institute of Hematology & Blood Diseases Hospital, China
Mayo Clinic
Case Comprehensive Cancer Center
Women's Hospital School Of Medicine Zhejiang University
Guangzhou University of Traditional Chinese Medicine
Indiana University
Peking Union Medical College Hospital
Abramson Cancer Center at Penn Medicine
Peking Union Medical College Hospital
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Mayo Clinic
University of Washington
Martini-Klinik am UKE GmbH
Chang Gung Memorial Hospital
Weill Medical College of Cornell University
Changhai Hospital
Peking Union Medical College
Changhai Hospital
Medical College of Wisconsin
Shandong Cancer Hospital and Institute
Arab American University (Palestine)
Peking Union Medical College Hospital
Cancer Research Antwerp
M.D. Anderson Cancer Center
Guangzhou University of Traditional Chinese Medicine
West China Hospital
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Karolinska University Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Gustave Roussy, Cancer Campus, Grand Paris
The Greater Poland Cancer Centre
Tata Memorial Centre
University of Cincinnati
Gansu Wuwei Tumor Hospital
University Hospital Tuebingen
Affiliated Hospital of Qinghai University
Jiangsu Province Nanjing Brain Hospital
Guangdong Association of Clinical Trials
Tianjin Medical University Cancer Institute and Hospital
Ruijin Hospital
Wuxi People's Hospital
Oslo University Hospital
University Hospital Ostrava
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Radiotherapy Oncology Centre "Santa Maria" Hospital
Fudan University
Zhejiang Cancer Hospital
Sunnybrook Health Sciences Centre
Hospices Civils de Lyon
The First Affiliated Hospital with Nanjing Medical University